ES2561672T3 - Inhibidores de fluorofosfato de arilo del cotransporte sodio/fosfato de la membrana apical intestinal - Google Patents

Inhibidores de fluorofosfato de arilo del cotransporte sodio/fosfato de la membrana apical intestinal Download PDF

Info

Publication number
ES2561672T3
ES2561672T3 ES11751437.2T ES11751437T ES2561672T3 ES 2561672 T3 ES2561672 T3 ES 2561672T3 ES 11751437 T ES11751437 T ES 11751437T ES 2561672 T3 ES2561672 T3 ES 2561672T3
Authority
ES
Spain
Prior art keywords
compound
formula
pharmaceutically acceptable
acceptable salt
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11751437.2T
Other languages
English (en)
Spanish (es)
Other versions
ES2561672T8 (es
Inventor
Brian Peerce
Larry Slomowitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DUOPHOS
Original Assignee
DUOPHOS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DUOPHOS filed Critical DUOPHOS
Application granted granted Critical
Publication of ES2561672T3 publication Critical patent/ES2561672T3/es
Publication of ES2561672T8 publication Critical patent/ES2561672T8/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/141—Esters of phosphorous acids
    • C07F9/146—Esters of phosphorous acids containing P-halide groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/14—Esters of phosphoric acids containing P(=O)-halide groups
    • C07F9/1406—Esters of phosphoric acids containing P(=O)-halide groups containing the structure Hal-P(=O)-O-aryl

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES11751437.2T 2010-03-05 2011-03-04 Inhibidores de fluorofosfato de arilo del cotransporte sodio/fosfato de la membrana apical intestinal Active ES2561672T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31090210P 2010-03-05 2010-03-05
US310902P 2010-03-05
PCT/US2011/027232 WO2011109731A2 (en) 2010-03-05 2011-03-04 Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport

Publications (2)

Publication Number Publication Date
ES2561672T3 true ES2561672T3 (es) 2016-02-29
ES2561672T8 ES2561672T8 (es) 2016-03-11

Family

ID=44542860

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11751437.2T Active ES2561672T3 (es) 2010-03-05 2011-03-04 Inhibidores de fluorofosfato de arilo del cotransporte sodio/fosfato de la membrana apical intestinal

Country Status (13)

Country Link
US (2) US8921343B2 (https=)
EP (1) EP2542560B8 (https=)
JP (1) JP5819865B2 (https=)
CN (1) CN102918050B (https=)
AU (1) AU2011222551B2 (https=)
BR (1) BR112012022349B1 (https=)
CA (1) CA2792093C (https=)
ES (1) ES2561672T3 (https=)
IL (1) IL221747A (https=)
MX (1) MX2012010288A (https=)
NZ (1) NZ602703A (https=)
RU (1) RU2566757C2 (https=)
WO (1) WO2011109731A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011222551B2 (en) * 2010-03-05 2016-10-06 Duophos Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport
WO2017111087A1 (ja) * 2015-12-25 2017-06-29 ステラケミファ株式会社 モノフルオロリン酸エステル塩、その製造方法及びフッ素イオン放出性組成物
CN119431437B (zh) * 2024-11-04 2025-09-30 山东花物堂生物科技有限公司 丹皮酚磷酸酯及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2371910A1 (en) * 1999-01-21 2000-07-27 Brian E. Peerce Inhibitors of intestinal apical membrane na/phosphate co-transportation
US7119120B2 (en) * 2001-12-26 2006-10-10 Genzyme Corporation Phosphate transport inhibitors
ATE337326T1 (de) * 2002-03-19 2006-09-15 Genzyme Corp Hemmer des phosphattransports
RU2279676C2 (ru) * 2003-06-16 2006-07-10 Уральская государственная академия ветеринарной медицины Способ контроля над репаративным остеогенезом у животных
ES2633689T3 (es) * 2009-01-26 2017-09-22 Opko Ireland Global Holdings, Limited Regulación de fosfato con moléculas pequeñas
AU2011222551B2 (en) * 2010-03-05 2016-10-06 Duophos Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport

Also Published As

Publication number Publication date
US20130059822A1 (en) 2013-03-07
EP2542560A4 (en) 2014-10-15
HK1180692A1 (zh) 2013-10-25
AU2011222551A1 (en) 2012-09-27
BR112012022349A2 (pt) 2016-07-05
EP2542560B8 (en) 2015-12-30
NZ602703A (en) 2015-01-30
WO2011109731A2 (en) 2011-09-09
US8921343B2 (en) 2014-12-30
MX2012010288A (es) 2013-02-27
AU2011222551B2 (en) 2016-10-06
BR112012022349B1 (pt) 2019-09-24
CA2792093C (en) 2018-05-22
US9328128B2 (en) 2016-05-03
US20150080597A1 (en) 2015-03-19
ES2561672T8 (es) 2016-03-11
RU2012142336A (ru) 2014-04-10
JP5819865B2 (ja) 2015-11-24
EP2542560A2 (en) 2013-01-09
CN102918050A (zh) 2013-02-06
CA2792093A1 (en) 2011-09-09
IL221747A (en) 2016-02-29
JP2013521337A (ja) 2013-06-10
RU2566757C2 (ru) 2015-10-27
CN102918050B (zh) 2015-07-01
WO2011109731A3 (en) 2012-03-01
EP2542560B1 (en) 2015-11-11

Similar Documents

Publication Publication Date Title
CA3105506A1 (en) Dimeric immuno-modulatory compounds against cereblon-based mechanisms
IL211429A (en) HISTORY 1 - Naphthalene triazole and a pharmaceutical composition containing them
ES2729713T3 (es) Compuestos tricíclicos, composiciones que los comprenden y usos de los mismos
CA3135740A1 (en) Cancer treatments targeting cancer stem cells
KR20150081365A (ko) 신규한 벤젠 설폰아미드 티아졸 화합물
WO2019204819A1 (en) Aminopyrazines and related compounds useful as mitochondrial uncouplers
ES2561672T3 (es) Inhibidores de fluorofosfato de arilo del cotransporte sodio/fosfato de la membrana apical intestinal
CN107438613A (zh) 用于预防或治疗感觉毛细胞死亡的化合物和方法
WO2022125613A1 (en) Phosphonates as inhibitors of enpp1 and cdnp
JPS5916869A (ja) 新規なｏ−フエニレンジアミン誘導体
US3925393A (en) Novel salts of vincanol
CN115968372A (zh) 辐射保护和化疗保护化合物
PT86776B (pt) Processo para a preparacao de acido piperazinocarboxilico e de composicoes farmaceuticas que o contem
US11958869B2 (en) Ruthenium arene Schiff-base complexes and uses thereof
TW201922690A (zh) 環－amp反應元素結合蛋白的抑制劑
HK1180692B (en) Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport
CN116768908B (zh) 一种含n多环化合物及其制备方法与用途
KR20130055391A (ko) 메트포르민의 가바 또는 가바 유도체 염, 이의 제조방법 및 이를 유효성분으로 함유하는 약제학적 조성물
CN111285900B (zh) 基于紫檀芪和香荚兰乙酮的偶联分子dcz0847类化合物、其制备方法及用途
CN108864114A (zh) 选择性a2a受体拮抗剂
WO2025010326A2 (en) Dimeric immuno-modulatory compounds against cereblon-based mechanisms
CN120698929A (zh) 一种联苯烯烃类化合物及其药物组合物和应用
CN118994004A (zh) (+)-sclerotiorin衍生物在抗分枝杆菌药物的应用
JPH02172988A (ja) １Ｈ―ピラゾロ〔３，４―ｂ〕ピラジン誘導体および該化合物を含有する抗腫瘍剤